ICMR excludes Molnupiravir from COVID-19 clinical management protocol
https://ift.tt/wEcZxH National National Task Force for COVID-19 of ICMR has made the decision to not include the antiviral drug Molnupiravir in the Clinical Management Protocol for now, official sources told news agency PTI on Tuesday (January 11).
donewssuper.blogspot.com DNA Web Team
donewssuper.blogspot.com DNA Web Team
0 Response to "ICMR excludes Molnupiravir from COVID-19 clinical management protocol"
Post a Comment